These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6814452)

  • 1. Enhancement of arterial thromboformation by uric acid, a free radical scavenger.
    Bourgain RH; Deby C; Deby-Dupont G; Andries R
    Biochem Pharmacol; 1982 Sep; 31(18):3011-3. PubMed ID: 6814452
    [No Abstract]   [Full Text] [Related]  

  • 2. Exchange of cyclooxygenase dependent metabolites between vessel wall and platelets in arterial thrombosis.
    Bourgain RH; Andries R; Decuyper K; Braquet P
    Thromb Res; 1988 May; 50(3):401-8. PubMed ID: 3134741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of free radical scavengers on "in vivo" induced arterial thrombosis in relation to the arachidonate cascade.
    Bourgain RH; Deby C; Andries R; Braquet P
    Prostaglandins Leukot Med; 1985 Jun; 18(3):353-8. PubMed ID: 3927319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibition of thromboxane A2 synthesis and thromboxane A2/prostaglandin endoperoxide receptors by ridogrel: anti-thrombotic effect in vivo in rat mesenteric arteries.
    Bourgain RH; Andries R; Decuyper K; De Clerck F
    J Lipid Mediat; 1991; 3(1):3-11. PubMed ID: 1837488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independence of the cyclic AMP-lowering activity of thromboxane A2 from the platelet release reaction.
    Gorman RR; Wierenga W; Miller OV
    Biochim Biophys Acta; 1979 Jan; 572(1):95-104. PubMed ID: 216409
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological action on the thromboxane and prostacyclin balance in the body].
    Lakin KM; Makarov VA; Novikova NV; Tret'iak VM; Rukazenkov IuE
    Farmakol Toksikol; 1984; 47(2):67-79. PubMed ID: 6425078
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation of cyclooxygenase by activated human neutrophils is enhanced by uric acid.
    Pincemail J; Deby C; Thirion A; Dethier A; Deby-Dupont G; Goutier R
    Prostaglandins; 1986 Jul; 32(1):101-5. PubMed ID: 3094096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin: a prostaglandin with therapeutic potential.
    Vane JR
    Arch Farmacol Toxicol; 1982 Aug; 8(2):51-76. PubMed ID: 6818907
    [No Abstract]   [Full Text] [Related]  

  • 9. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of cicletanine on prostacyclin generation in vivo].
    Bourgain RH; Deby C; Andries R
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():33-6. PubMed ID: 2514665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effect of PGI2 (prostacyclin) on white platelet arterial thrombus formation.
    Bourgain RH
    Haemostasis; 1979; 8(2):117-9. PubMed ID: 387547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of prostacyclin in vascular tissue.
    Moncada S; Vane JR
    Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of prostacyclin synthetase by cicletanine and drugs which affect ion transport.
    Deby C; Bourgain RH; Andries R; Braquet P
    Pharmacol Res Commun; 1988 Sep; 20 Suppl 3():101-8. PubMed ID: 3147465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators.
    MacIntyre DE; Bushfield M; MacMillan LJ; Moffat KJ; Murdoch FA; Thomson A; Rossi AG; McNicol A
    Agents Actions Suppl; 1986; 20():45-62. PubMed ID: 3028106
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
    Fitzgerald DJ; Doran J; Jackson E; FitzGerald GA
    J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of prostaglandin I2 and thromboxane A2 on circulating negative inotropic agents released from acid aspiration pneumonia in dogs].
    Utsunomiya T; Okabe M; Namikawa K; Nogami T
    Kokyu To Junkan; 1985 Oct; 33(10):1243-9. PubMed ID: 3909280
    [No Abstract]   [Full Text] [Related]  

  • 17. A role for uric acid in the progression of renal disease.
    Kang DH; Nakagawa T; Feng L; Watanabe S; Han L; Mazzali M; Truong L; Harris R; Johnson RJ
    J Am Soc Nephrol; 2002 Dec; 13(12):2888-97. PubMed ID: 12444207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane A2 and prostacyclin formation in rats fed cod-liver or sunflower oil.
    Nutr Rev; 1982 May; 40(5):157-9. PubMed ID: 6808427
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo.
    Ogletree ML; Harris DN; Heran CL; Phillips MB; Michel IM; Goldenberg HJ
    Eicosanoids; 1988; 1(2):85-91. PubMed ID: 2856188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of prostaglandins in platelet-vessel wall interaction.
    Bourgain RH; Andries R; Finne E
    Arch Int Pharmacodyn Ther; 1979 May; 239(1):161-3. PubMed ID: 384949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.